Optimal Management of Heart Failure with Preserve Ejection Fraction.
10.3904/kjm.2015.88.2.135
- Author:
Soo Jin NA
1
;
Sang Hong BAEK
Author Information
1. Department of Cardiovascular, The Catholic University of Korea Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. whitesh@catholic.ac.kr
- Publication Type:Review
- Keywords:
Heart Failure, Diastolic;
Treatment
- MeSH:
Diagnosis;
Epidemiology;
Heart Failure*;
Heart Failure, Diastolic;
Humans;
Mortality;
Prognosis
- From:Korean Journal of Medicine
2015;88(2):135-141
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
More than 50% of patients who are diagnosed with heart failure have preserved ejection fraction (HFpEF), and they have an equally poor prognosis when compared to patients with heart failure with reduced ejection fraction (HFrEF). However, a comprehensive understanding and awareness of heart failure with preserved ejection fraction is still limited and there are currently no optimized treatments to improve morbidity and mortality in these patients. This review summarizes the differences in the epidemiology, pathophysiology, diagnosis, and prognosis between HFpEF and HFrEF. We also review current management strategies of HFpEF patients according to evidence-based treatment guidelines.
